Home › Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test
 

Keywords :   


Orasure Technologies Receives FDA Emergency Use Authorization for Ebola Rapid Diagnostic Test

2015-08-03 19:27:07| Biotech - Topix.net

OraSure Technologies, Inc. , a leader in point of care diagnostic tests and specimen collection devices, announced today that it has received a U.S. Food and Drug Administration Emergency Use Authorization for its OraQuick Ebola Rapid Antigen Test for use with fingerstick and venous whole blood. This test has not been cleared or approved by FDA.

Tags: test technologies rapid emergency

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »